private:inscopix
|
2468676
|
May 29th, 2019 12:00AM
|
Inscopix, Inc.
|
1.6K
|
52.00
|
Open
|
Biotechnology
|
May 28th, 2019 11:56PM
|
May 28th, 2019 11:56PM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
Open
|
neuroscience, life science research tools, in vivo brain imaging, electrophysiology, neurotechnology, miniature microscope, calcium imaging
|
Open
|
2462 Embarcadero Way
|
Palo Alto
|
CA
|
US
|
94303
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 17th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 16th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 15th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 14th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 13th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 12th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 11th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 10th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:inscopix
|
2468676
|
Feb 9th, 2018 12:00AM
|
Inscopix, Inc.
|
1.2K
|
53.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
|
|
|
|
|
|
|
|
|
|
Inscopix
|
Health Care
|
Pharmaceuticals & Biotechnology
|